Clinical Trials Browser

NCT06694454 2026-03-18

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Not yet recruiting

60 enrolled

Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT07391670 2026-03-12

IMFINZI-subQ

Phase 1 Not yet recruiting

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT07459634 2026-03-10

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Phase 2 Not yet recruiting

50 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07361497 2026-02-19

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Phase 3 Not yet recruiting

850 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07247786 2025-12-30

MIGRANT

Phase 2 Not yet recruiting

68 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms

NCT06998719 2025-05-31

ACCESS

Phase 2 Not yet recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06719336 2024-12-05

Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)

Phase 3 Not yet recruiting

182 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT05484583 2022-08-05

Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases

Phase 2 Not yet recruiting

58 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04465968 2020-07-10

DEEP_OCEAN

Phase 3 Not yet recruiting

84 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Pancoast Syndrome